Malaria Transmission After Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine: A Randomized Trial

Thumbnail
View/Open
Date
2013-03-06
Author
Sawa, Patrick
Shekalaghe, Seif A.
Drakeley, Chris J.
Sutherland, Colin J.
Mweresa, Collins K.
Baidjoe, Amrish Y.
Manjurano, Alphaxard
Kavishe, Reginald A.
Beshir, Khalid B.
Yussuf, Rahma U.
Omar, Sabah A.
Hermsen, Cornelus C.
Okell, Lucy
Schallig, Henk D. F. H.
Sauerwein, Robert W.
Hallett, , Rachel L.
Bousema, Teun
Metadata
Show full item record
Abstract
Artemisinin-based combination therapy (ACT) reduces the potential for malaria transmission, compared with non-ACTs. It is unclear whether this effect differs between ACTs.
URI
http://ir.tum.ac.ke/handle/123456789/17568
Collections